L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression (Q39693828)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 14 June 2010

Language	Label	Description	Also known as
English	L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression	scientific article published on 14 June 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

0 references

1 reference

based on heuristic

inferred from title

pancreatic adenocarcinoma

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

H Kiefel

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

S Bondong

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

N Erbe-Hoffmann

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

J Hazin

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

S Riedle

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

J Wolf

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

M Pfeifer

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

H Schäfer

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

S Sebens Müerköster

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

P Altevogt

11

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

14 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4766-4778

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Activation of cell-survival transcription factor NFkappaB in L1Ig6-stimulated endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

21 January 2018

Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Targeting cancer stem cells through L1CAM suppresses glioma growth

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

The RGD integrin binding site in human L1-CAM is important for nuclear signaling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Kinetic analysis of L1 homophilic interaction: role of the first four immunoglobulin domains and implications on binding mechanism

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Integrin-linked kinase: a cancer therapeutic target unique among its ILK.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Structural and functional evolution of the L1 family: are four adhesion molecules better than one?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1 is associated with micrometastatic spread and poor outcome in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

ILK, PINCH and parvin: the tIPP of integrin signalling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

The adhesion molecule L1 (CD171) promotes melanoma progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Integrin and neurocan binding to L1 involves distinct Ig domains

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Pancreatic cancer: basic and clinical aspects

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.230

31 March 2020

Identifiers

10.1038/ONC.2010.230

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39693828&oldid=2203095141"